Skip to content

Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia

Cardiovascular Performance and Autonomic Reactivity in Formerly Preeclamptic Women With a Contracted Plasma Volume (CAPACITY Trial)

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00117546
Enrollment
35
Registered
2005-07-07
Start date
2005-09-30
Completion date
2008-12-31
Last updated
2010-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Keywords

CAPACITY trial, preeclampsia, plasma volume, sympathetic activity, hypertension, cardiovascular system

Brief summary

A history of preeclampsia is associated with a low plasma volume and higher sympathetic activity. Methyldopa will suppress sympathetic activity to normal values. In this study, the researchers will test that effect on the total cardiovascular balance.

Detailed description

This is a randomized double-blind placebo controlled cross-over study in formerly preeclamptic women with a contracted plasma volume. The researchers will test the effect of methyldopa on the cardiovascular balance and orthostatic tolerance in women with a history of preeclampsia and healthy controls.

Interventions

DRUGalpha methyldopa

500 mg twice a day

Sponsors

Radboud University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
DOUBLE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Primiparous * History of preeclampsia * Low plasma volume

Exclusion criteria

* Thrombophilia * Hypertension * Auto-immune disorder * Insulin dependent diabetes mellitus

Design outcomes

Primary

MeasureTime frame
normalized plasma volume1 month

Secondary

MeasureTime frame
increased orthostatic tolerance1 month
normalized cardiovascular balance1 month
venous capacitance1 month

Countries

Netherlands

Contacts

Primary ContactM.E.A Spaanderman, MD, PhD
m.spaanderman@obgyn.umcn.nl+31 24 36 13401

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026